MondayJan 29, 2018 1:55 pm

The Green Organic Dutchman Boosts Financing to $160 Million with Strategic Investment by Aurora Cannabis

The Green Organic Dutchman Holdings Ltd., also known as TGOD, recently announced the closing of $112 million in private placement financing, including a strategic investment by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) of $55 million. TGOD issued 67,878,788 units at a price of $1.65 per unit. Each unit included one common share of the company and a half common share purchase warrant that can be converted to a full share at the exercise price of $3 each during the next three years. The investment fully funds the expansion of TGOD’s combined 970,000 square-foot ultra-high technology greenhouse…

Continue Reading

FridayJan 26, 2018 1:11 pm

NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) – From Nutraceuticals to Cannabinoid Pharmaceuticals

Patented nutraceuticals with retail distribution and consumer branding expertise MOU with cannabinoid pharma for research on NeutriSci products for new therapeutics Targeting forefront of new and innovative cannabinoid-based medical products in Canada In business for nearly a decade, NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) has become an established leader in the Canadian nutraceutical markets and continues to develop new sales channels throughout the U.S., Europe and Asia. The company is not only expanding its existing national retail footprint in Canada; it just entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. to develop, produce…

Continue Reading

FridayJan 26, 2018 9:40 am

Choom™ (CSE: CHOO) (OTCQB: CHOOF) Cultivating an Exceptional Consumer Experience

Branding and retail focused to capture large share of $8.7 billion Canadian recreational cannabis market Developing chain of branded retail cannabis dispensaries – just announced new retail store concept Intends to establish a significant retail footprint in the Canadian recreational cannabis markets The laid back Hawaiian lifestyle is the envy of the world. Surfers and sun worshipers enjoy life and, for decades, have relaxed with ‘choom’, the local name for marijuana. Now a company, Choom™ (CSE: CHOO) (OTCQB: CHOOF) is bringing the spirit and lifestyle of Hawaii to Canada. Choom™ is a high-quality hand-crafted cannabis brand created exclusively for the…

Continue Reading

ThursdayJan 25, 2018 3:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Offers Potentially Safer Method of Delivering Drug Therapies

Only company in the world with patent for the oral or ingestible delivery of all non-psychoactive cannabinoids Uplisted to OTCQX® Best Market Licensing model generates profit margins in excess of 90 percent A new report by the National Academies of Sciences, Engineering and Medicine is the most comprehensive analysis of existing research on e-cigarettes, according to the New York Times (http://cnw.fm/Eay21). While warning against the risk of nicotine addiction posed by vaping, the report claimed “that the devices are safer than traditional smoking products and may help smokers quit, citing conclusive proof that switching can reduce smokers’ exposure to deadly…

Continue Reading

ThursdayJan 25, 2018 12:35 pm

Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) Closes $2 Million in Private Placement Financing

Company’s subsidiaries set sights on recreational use licensing, expansion Total marijuana market in Canada forecast to hit $2.8 billion by 2020 Pet cannabis products for pain expected to form large market opportunity Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) announced on January 22 that it had closed a private placement financing effort with $2 million in gross proceeds that will be used to speed completion of facility construction projects for its subsidiaries, North Road Ventures in the greater Vancouver area of Canada’s British Columbia and Just Kush Enterprises, located some 250 miles to the east. Just Kush…

Continue Reading

TuesdayJan 23, 2018 1:07 pm

Disrupting Drug Delivery Platform Keeps Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Portfolio Growing

Patented technology promotes healthier administration of active pharmaceutical ingredients, including cannabidiol (CBD), psychoactive cannabinoids (THC), nicotine, fat soluble vitamins and nonsteroidal anti-inflammatory drugs Active pharmaceutical ingredient market expected to exceed $239 billion by 2025 19 patent applications filed in U.S. and internationally encompassing 44 countries Lab tests in 2018 include topical CBD skin cream, nicotine in edible formats Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million…

Continue Reading

FridayJan 19, 2018 12:27 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Combining Nature and Science to Make Life Better

Company utilizing novel Caribbean blue scorpion venom therapy for immune system boost PreveCeutical seeks new ways to treat cancers, metabolic disorders, pain, infectious diseases and cardiovascular disease Partnership with University of Queensland researchers advances scientific scope of projects In the modern health care industry, disease prevention has taken a commanding role as screenings and regularly scheduled physician visits aim to minimize costs that could otherwise spiral out of control once a chronic condition is established. However, the Centers for Disease Control and Prevention report an ongoing concern that Americans are using preventive services at about half the recommended rate (http://cnw.fm/OIa4V).…

Continue Reading

ThursdayJan 11, 2018 2:34 pm

2017 was a Transformative Year for Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP)

Lexaria’s CEO posts end of 2017 summary Multiple transformative developments – IP strengthened, broad patents awarded, finances secured Foundation for the future established – multiple opportunities on horizon If the past is any prologue, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) should have a break out year in 2018. Lexaria’s CEO, Chris Bunka, recently posted ‘LXRP CEO’s End of 2017 Summary’. It was a transformative year with multiple accomplishments that should establish a strong foundation for the future. Lexaria Bioscience has developed, patented and commercialized a cost-effective lipophilic delivery technology, DehydraTECH™, to enhance the performance of beneficial compounds in ingestible…

Continue Reading

TuesdayJan 02, 2018 2:36 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Marks Milestone with Patent Approval

LXRP awarded broad-ranging U.S. patent for novel DehydraTECH™ drug delivery system Already scientifically proven to increase efficacy of cannabinoids IP protection opens myriad business opportunities Food bioscience company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) just hit another major milestone in the disruption of drug delivery and administration. With 19 international patent applications filed encompassing 44 countries, Lexaria recently announced its reception of a broad-ranging U.S. patent award for its DehydraTECH™ as a delivery platform for a wide variety of active pharmaceutical ingredients (http://cnw.fm/2KT1d). The U.S. patent covers all cannabinoids including THC, fat soluble vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977